Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Similar documents
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

RESEARCH GOVERNANCE POLICY

Corporate. Research Governance Policy. Document Control Summary

Document Title: Document Number:

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Research Database Application (ReDA) Document Number: 043

Safety Reporting in Clinical Research Policy Final Version 4.0

Document Title: Research Database Application (ReDA) Document Number: 043

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

Document Title: Investigator Site File. Document Number: 019

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

GCP Training for Research Staff. Document Number: 005

Central Alerting System (CAS) Policy

Gaining NHS Trust R&D Approvals

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Document Title: File Notes. Document Number: 024

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures

Standard Operating Procedure (SOP) Research and Development Office

Document Title: Informed Consent for Research Studies

Document Title: Study Data SOP (CRFs and Source Data)

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

Document Title: Training Records. Document Number: SOP 004

Document Title: Version Control of Study Documents. Document Number: 023

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

STANDARD OPERATING PROCEDURE SOP 325

Document Title: Recruiting Process. Document Number: 011

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

NHS REC Applications

EAST & NORTH HERTS, HERTS VALLEYS CCGS SAFEGUARDING CHILDREN & LOOKED AFTER CHILDREN TRAINING STRATEGY

Advanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016

SAFEGUARDING CHILDEN POLICY. Policy Reference: Version: 1 Status: Approved

Access to Health Records Procedure

Auditing of Clinical Trials

Human Research Governance Review Policy

Human Research Ethics Review Policy

The NHS Constitution

Research Staff Training

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

CLINICAL RESEARCH POLICY

JOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

NHS Constitution The NHS belongs to the people. This Constitution principles values rights pledges responsibilities

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

STH Researcher. Recording of research information in patient case notes

GUIDELINES ON SECTION 17 LEAVE OF ABSENCE MHA (1983)

Standard Operating Procedure Research Governance

Standard Operating Procedure (SOP)

GUIDELINE FOR THE USE OF KEYS AND KEYSAFE CODES FOR ADULT COMMUNITY HEALTH TEAM WORKERS

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

The changing regulatory and governance environment. for health research across the UK. a guide for researchers. November 2009 v.1

RESEARCH GOVERNANCE POLICY

Specialised Services: CPL-008 Referral Management Policy

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

SCDHSC0335 Contribute to the support of individuals who have experienced harm or abuse

Quality of Care Approach Quality assurance to drive improvement

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

Trial Management: Trial Master Files and Investigator Site Files

Health & Safety Policy. Author:

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Regulation of Medical Herbalists, Acupuncturists and Traditional Chinese Medicine Practitioners

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Ethical framework for priority setting and resource allocation

Standard Operating Procedures (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Subject: Safeguarding of Service Users Finances HSC(F) within Residential and Nursing Homes and Supported Living Settings.

Health and Safety Strategy

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

JOB DESCRIPTION. Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Employment Policies and Procedures. Breastfeeding Supporting Staff Policy

POLICY ON RESEARCH RELATED ADVERSE EVENT REPORTING

JOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme

Registered charity no: Grant application form. The Royal Society of St George Charitable Trust (c) Grant application form v1 22 June 2016

NHS Research Scotland Permissions Coordinating Centre

Patient Experience Strategy

Ref No: 2135 Title: Liquidised food through enteral feeding tubes in the community (Paediatric SOP) Version No: 1. Date of Issue: 10 March 2017

STANDARD OPERATING PROCEDURE

Marie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

ABMU R&D Operational Framework

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure:

GPs apply for inclusion in the NI PMPL and applications are reviewed against criteria specified in regulation.

NIHR Guideline B01 R&D Operational Capability Statement for Dorset HealthCare University NHS Foundation Trust

Name of Researcher: Professor Kimme Hyrich. PARTICIPANT INFORMATION SHEET Version 8.0; 19 th October 2016

JOB DESCRIPTION. CHC/Complex Care Administrator. Continuing Healthcare/Complex Care. Operational Lead. Administration CHC/Complex Care

Keele Clinical Trials Unit

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

Transcription:

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES Author s Name Author s Job Title Division Department F Smith Research & Development (R&D) Manager Medical Executive R&D Version number 2 Ratifying Committee Clinical Governance Ratified Date October 2009 Review Date October 2011 Manager responsible for review F Smith Job title of manager responsible for review R&D Manager E-mail address for this Manager Fiona.smith@whht.nhs.uk Source of Evidence (If applicable) MHRA, NRES Level of Evidence indicated National Referenced (Yes/No) Yes Key words (to aid searching) Research, study, procedure, start User Group Research Staff Previous version v1, Sept 2008 Location of archived copy R&D Office The Trust is committed to promoting an environment that values diversity. All staff are responsible for ensuring that all patients and their carers are treated equally and fairly and not discriminated against on the grounds of race, sex, disability, religion, age, sexual orientation or any other unjustifiable reason in the application of this policy, and recognising the need to work in partnership with and seek guidance from other agencies and services to ensure that special needs are met. 1

BACKGROUND Before commencing a research study it is essential to ensure that it complies with all legal and ethical requirements. The Research Governance Framework 2001 states that the Department of Health requires that research involving patients, service users, care professionals or volunteers, or their organs, tissue or data, is reviewed independently to ensure it meets ethical standards. The National Research Ethics Service (NRES) works with colleagues in the UK to maintain a UK-wide system of ethical review that protects the safety, dignity and well-being or research participants, whilst facilitating nd promoting ethical research within the NHS. Paragraph 3.10.4 of the Research Governance Framework summarises the main responsibilities of organisations providing care. These include that: they be aware and maintain a record of all research they ensure that: all research involving participants for whom they are responsible has ethical approval and a person authorised to do so has given written permission on behalf of the organisation providing care. INTRODUCTION Local Management approval is therefore required for all studies undertaken in the NHS. The s review research studies in the Trust to decide whether or not they should be allowed to proceed. The R&D department advises and assists researchers to get studies started and obtain the necessary approval. PURPOSE The purpose of this SOP is to describe the procedures for obtaining Ethics, Regulatory body and R&D approval prior to starting a research study. PROCESS WHO? It is the responsibility of the local investigator to liaise with the R&D department to ensure that the correct procedure is followed. It is the responsibility of the Director of R&D to sign off the study when ethics and R&D approval have been obtained. WHEN? The study documents should be sent to R&D at the same time as the project is submitted to NRES. 2

HOW? Initially it is important to establish the type of research study that is proposed. The type of Ethics application depends on many factors such as whether the study is single site or multi-site and whether there is to be a local researcher or not. A study should be identified as one of the following so that the correct approval procedure can be followed: Type of Study Single Site study with a Chief Investigator Multiple site study with a Trust site as the primary site and Chief Investigator Multiple site study with MREC approval and a local Principal Investigator MREC approved study previously specified as no local investigator (NLI) or SSA Exempt Required Approval Full Ethics and R&D approval Full Ethics and R&D approval R&D approval R&D approval Make sure that you have applied for any necessary approval and certificates from appropriate statutory regulatory authorities via IRAS (www.myresearchproject.org.uk). for research involving medicinal products see the website www.mhra.gov.uk, www.emea.eu.int or http://eudract.emea.eu.int). for research into uses of medical devices see the website for the Medicines and Healthcare products Regulatory Agency (www.mhra.gov.uk How we regulate Devices Clinical Trials. Please refer to the Research Governance Policy for additional information. Ethics Applications Guidance is available at www.nres.npsa.nhs.uk R&D Approval Please submit the following documents to wherts-tr.rdapplications@nhs.net Protocol Completed SSIF form (see ethics page for full instructions on the completion of this form) Copy of Ethics form parts A and B (pdf file) Copy of Ethics from parts A and B as XML file Patient Information Sheet Upon receipt of the above, the review of the project will commence. When available, please forward, electronically if at all possible, the following additional documents, to the Email address above SSIF signature pages Ethics approval letter MHRA Clinical Trial Authorisation (if applicable) Clinical Trial Agreement 3

Local versions of all approved patient documents (on hospital headed paper) Copies of any approved adverts or posters to be used Sponsors letter Costing pro-forma Hard copies of any documents not available electronically should be sent to R&D Department The Clock tower Mount Vernon Hospital Rickmansworth Road Northwood Middlesex HA6 2RN For researchers using CSP (Coordinated System for gaining NHS Permissions) please follow the guidance from the lead CLRN. RESPONSIBILITIES Chief investigator, investigators, other researchers: Developing proposals that are scientifically sound and ethical Submitting the design for independent expert review Submitting the study (or proposal) for independent ethical review Conducting a study to the agreed protocol (or proposal) in accordance with legal requirements, guidance and accepted standards in good practice Preparing and providing information for participants Ensuring participants welfare while in the study Arranging to make findings and data accessible following expert review Feeding back the results of research to participants Sponsor: Confirming that everything is ready for the research to begin: o taking on responsibility for putting and keeping in place arrangements to initiate, manage and fund the study o satisfying itself that the research protocol, team and environment have passed appropriate scientific quality assurance o satisfying itself that the study has ethical approval before it begins o for clinical trials involving medicines, seeking a clinical trial authorisation and making arrangements for investigational medicinal products Satisfying itself that arrangements are kept in place for good practice in conducting the study and for monitoring and reporting, including prompt reporting of suspected unexpected serious adverse events or reactions. Employing organisation: promoting a quality research culture 4

ensuring researchers understand and discharge their responsibilities ensuring studies are properly designed and submitted for independent review ensuring studies are managed, monitored and reported as agreed, according to the protocol providing written procedures, training and supervision taking action if misconduct or fraud is suspected Organisation providing care: Arranging for an appropriate person to give permission for research involving their patients, service users, carers or staff, before the research starts Ensuring any such research is conducted to the standards set out in the research governance framework Requiring evidence of ethical review before recruitment to any research that affects their duty of care Before recruitment to trials with medicines, requiring evidence of a positive ethical opinion and a clinical trials authorisation Retaining responsibility for the care of participants to whom they have a duty. 5